NGM stock forecast
Our latest prediction for Ngm Biopharmaceuticals Inc's stock price was made on the Feb. 3, 2023 when the stock price was at 5.40$.
In the short term (2weeks), NGM's stock price should underperform the market by -2.35%. During that period the price should oscillate between -9.74% and +7.42%.
In the medium term (3months), NGM's stock price should underperform the market by -5.47%. During that period the price should oscillate between -28.97% and +18.25%.
Get email alertsCreate a solid portfolio with NGM
About Ngm Biopharmaceuticals Inc
NGM is a biopharmaceutical company focused on discovering and developing novel therapeutics based on scientific understanding of key biological pathways underlying liver and metabolic diseases, retinal diseases and cancer. The Company leverages its biology-centric drug discovery approach to uncover novel mechanisms of action and generate proprietary insights that enable it to move rapidly into proof-of-concept studies and deliver potential first-in-class medicines to patients. NGM aspires to operate one of the most productive research and development engines in the biopharmaceutical industry.
At the moment the company generates 231M USD in revenues.
On its last earning announcement, the company reported a loss of -1.38$ per share.
The book value per share is 2.88$
Three months stock forecastFeb. 3, 2023
Financials
| Revenue USD | Gross Margin | Operating Income | Operating Margin | Net Income | Earnings Per Share | Dividends | Payout Ratio | Shares | Book Value Per Share | Operating Cash Flow | Cap Spending | Free Cash Flow |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 231M | 25.13% | -155M | -67.12% | -103M | -1.38 | - | - | 81M | 2.88 | - | - | - |